Bevacizumab/Trastuzumab-deruxtecan
Fields of Study & Subjects
HER2/EGFR in Cancer Research
Gastric Cancer Management and Outcomes
Pharmacovigilance and Adverse Drug Reactions
Publication details
- Journal / source
- Reactions Weekly
- Volume
- 2100
- Issue
- 1
- Pages
- 33–33
- Publication date
- 7 March 2026
- Language
- EN